MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Prediction of Risk and Complications
A preprocedural risk model can help patients and health care providers alike
By David R. Holmes, Jr, MD, and Mandeep Singh, MD
New Insights From the STS/ACC TVT Registry
What these ongoing data tell us about TAVR and future areas of interest.
By Frederick L. Grover, MD, and David R. Holmes Jr, MD
Annual Outcomes From the STS/ACC TVT Registry Evaluate Transcatheter Valve Therapy
November 30, 2015—David R. Holmes, Jr, MD, et al published a report of the annual outcomes of transcatheter valve therapy (TVT) from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) TVT Registry, which is available online ahead of print in Annals of Thoracic Surgery and Journal of the American College of Cardiology.
ACC and STS Issue Expert Consensus Document on Transcatheter Valve Therapy
June 27, 2011—The American College of Cardiology (ACC) and the Society of Thoracic Surgeons (STS) have published an expert consensus document on transcatheter valve therapy.
Long-Term Data Reported From Continued Access Registries of Boston Scientific's Watchman LAAC Device
December 2, 2019—Findings from continued access registries on the long-term safety and efficacy of the Watchman left atrial appendage closure (LAAC) device (Boston Scientific Corporation) for stroke prevention in patients with nonvalvular atrial registries were published by David R. Holmes Jr, MD, et al in Journal of the American College of Cardiology (JACC; 2019;74:2878–2889). The investigators sought to evaluate 4.5- to 5-year data in two FDA-mandated registries for safety and efficacy of LAAC with the Watchman device: CAP (Continued Access to PROTECT-AF) and CAP2 (Continued Access to PREVAIL).
Managing Complications
By Ted E. Feldman, MD, Chief Medical Editor
Multisociety Consensus Document Offers Guidance for TAVR
January 31, 2012—A multisociety expert consensus document from the American College of Cardiology Foundation (ACCF), the American Association for Thoracic Surgery (AATS), the Society for Cardiovascular Angiography and Interventions (SCAI), and the Society of Thoracic Surgeons (STS) was published to provide guidance on the use of transcatheter aortic valve replacement (TAVR) to treat patients with aortic valvular stenosis.
TAVR: Insights and Perspectives
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
CMS Initiates National Coverage Analysis of TAVR
September 29, 2011—The US Centers for Medicare & Medicaid Services (CMS) has initiated a National Coverage Analysis (NCA) of transcatheter aortic valve replacement (TAVR). CMS stated that it received a formal national coverage determination (NCD) request from the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC). According to CMS, STS and ACC advised the agency that clinical trial data shows that the most successful patient outcomes occur when the following criteria are met: the procedure is performed in a specialized heart center and managed using a multidisciplinary team in which each member has appropriate training and credentials (requirements are currently under development for this); the procedure is performed in a modified conventional cardiac laboratory or hybrid operating room that contains the specialized equipment necessary for the procedure; and the multidisciplinary team uses a planned approach to co-manage decision making as well as technical insertion of the device.
STS/ACC Launch Registry for Transcatheter Valve Therapy
December 1, 2011—The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) announced the launch of the first-of-its-kind registry to monitor the safety and efficacy of transcathether aortic valve replacement therapy (TAVR), which was approved by the US Food and Drug Administration (FDA) in November 2011 for elderly patients with aortic stenosis who are too sick, frail, or high risk for surgical therapy.
Ask the Experts: Should the CMS NCD Requirement for Surgical and Interventional Co-Operators for TAVR Procedures Be Dropped?
With John C. Alexander, MD; Atul Chawla, MD; David X. Zhao, MD; Nirat Beohar, MD, FACC, FSCAI; and Mohamed Abdel-Wahab, MD, FESC
Discharge Management of Patients With Diabetes and ACS
Optimizing long-term outcomes.
By Suzanne V. Arnold, MD, MHA, and Mikhail Kosiborod, MD
Patent Foramen Ovale Closure for Cryptogenic Stroke
Developing a treatment strategy guided by clinical data.
By HoHai Van, MD, and Jonathan Tobis, MD
Anticoagulation Management After Watchman Implantation
Current indications for antiplatelet agents and NOACs after Watchman implantation.
By Mathieu Lempereur, MD, and Adel Aminian, MD
